← Back to Search

Pacemaker

Aveir VR Leadless Pacemaker for Arrhythmia

N/A
Waitlist Available
Research Sponsored by Abbott Medical Devices
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Summary

This trial is testing the safety and effectiveness of the Aveir LP System, a pacemaker for patients with slow heart rhythms. The device helps the heart maintain a regular beat by sending electrical signals.

Eligible Conditions
  • Arrhythmia
  • Slow Heart Rate

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Complication-Free Rate
Pacing thresholds and R-wave amplitudes within the therapeutic range
Secondary outcome measures
Appropriate and proportional rate response during graded exercise testing
Survival Rate of Patients implanted with the Nanostim Leadless Pacemaker

Trial Design

1Treatment groups
Experimental Treatment
Group I: Aveir VR Leadless PacemakerExperimental Treatment1 Intervention
VVIR pacing

Find a Location

Who is running the clinical trial?

Abbott Medical DevicesLead Sponsor
644 Previous Clinical Trials
405,760 Total Patients Enrolled
18 Trials studying Arrhythmia
10,434 Patients Enrolled for Arrhythmia
~69 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top